Alison Birtle
0000-0002-2621-0909
Publication & Citation Trends
Publications
247 total
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
Cited by 193
OpenAlex
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
Cited by 484
OpenAlex
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial PDF
Cited by 517
OpenAlex
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial PDF
Cited by 396
OpenAlex
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort† PDF
Cited by 190
OpenAlex
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial PDF
Cited by 1,239
OpenAlex
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol PDF
Cited by 247
OpenAlex
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy PDF
Cited by 1,744
OpenAlex
Research Topics
Prostate Cancer Treatment and Research
(110)
Bladder and Urothelial Cancer Treatments
(96)
Radiopharmaceutical Chemistry and Applications
(50)
Urinary and Genital Oncology Studies
(42)
Prostate Cancer Diagnosis and Treatment
(34)
Affiliations
University College Hospital
Lancashire Teaching Hospitals NHS Foundation Trust
Institute of Cancer Research
University of Liverpool
University Hospitals of Morecambe Bay NHS Foundation Trust